In the BioHarmony Drug Report Database

"Preview" Icon

Lumacaftor

Orkambi (lumacaftor) is a small molecule pharmaceutical. Lumacaftor was first approved as Orkambi on 2015-07-02. It is used to treat cystic fibrosis in the USA. It has been approved in Europe to treat cystic fibrosis. It is known to target cystic fibrosis transmembrane conductance regulator. Orkambi’s patents are valid until 2030-12-11 (FDA).

 

Trade Name

 

Orkambi
 

Common Name

 

lumacaftor
 

ChEMBL ID

 

CHEMBL2103870
 

Indication

 

cystic fibrosis
 

Drug Class

 

Cystic fibrosis transmembrane regulator (CFTR) protein modulators

Image (chem structure or protein)

Lumacaftor structure rendering